Seeing Is Believing
SKYE is currently covered by 1 analysts
Skye Bioscience, Common Stock's activity chart (see below) currently has 8 price targets and 11 ratings on display. The stock rating distribution of SKYE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 7.33 days.
Highest price target for SKYE is $4, Lowest price target is $2.
Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 24-Jun-2025. First documented stock forecast 05-Feb-2024.
Currently out of the existing stock ratings of SKYE, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2024
$15
$13.99 (1385.15%)
Buy Since 23-May-2024
$14
$12.99 (1286.14%)
$14
Buy Since 05-Feb-2024
$12
What is SKYE (Skye Bioscience, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?
Which analyst has the current lower performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?
Which analyst has the most public recommendations on SKYE (Skye Bioscience, Common Stock)?
Which analyst is the currently most bullish on SKYE (Skye Bioscience, Common Stock)?
Which analyst is the currently most reserved on SKYE (Skye Bioscience, Common Stock)?